Form 4: Meta Platforms' Chief Product Officer Christopher Cox Sells Shares Under 10b5-1 Trading Plan

Christopher K. Cox, Chief Product Officer of Meta Platforms, Inc., executed multiple sales of Class A Common Stock on February 26, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On February 26, 2025, Christopher K. Cox, the Chief Product Officer of Meta Platforms, Inc., sold shares of Class A Common Stock.
• The sales were executed under a Rule 10b5-1 trading plan adopted on November 27, 2024.
• The transactions involved multiple sales at varying weighted average prices, ranging from $658.10 to $672.02 per share.
• Cox sold a total of 18,706 shares on this day.
• Following the reported transactions, Cox directly owns 55,046 shares through the Cox-Vadakan Irrevocable Remainder Trust and indirectly owns 328,686 shares through the Christopher K. Cox Revocable Trust.

Sentiment

Score: 5

Explanation: The document itself is neutral, simply reporting the facts of the stock sale. The sentiment is neither positive nor negative as it's a routine transaction under a pre-arranged plan.

Industry Context

Insider sales are a common occurrence in publicly traded companies and are often conducted under pre-arranged trading plans like Rule 10b5-1 to avoid accusations of trading on non-public information. The market typically analyzes these sales in the context of the overall financial health and future prospects of the company.

Comparison to Industry Standards

• Comparing Christopher Cox's sales to other C-level executives at FAANG companies is difficult without knowing the specific details of their compensation packages and trading plans.
• However, it's common for executives at large tech companies like Apple, Amazon, Netflix, and Google (Alphabet) to have similar arrangements for selling shares over time.
• These sales are often a part of their overall compensation and wealth management strategies.

Stakeholder Impact

• The sale of shares by a high-ranking executive could be perceived negatively by some shareholders, potentially leading to minor short-term price fluctuations.
• However, given the pre-planned nature of the sales under Rule 10b5-1, the impact is likely to be minimal.

Key Dates